BIOA BioAge Labs, Inc.
Healthcare$16.61-0.78%ClosedMarket Cap: $625.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.86
P/S
60.62
EV/EBITDA
-4.20
DCF Value
$9.00
FCF Yield
-14.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.4%
Operating Margin
-985.9%
Net Margin
-871.8%
ROE
-29.4%
ROA
-22.6%
ROIC
-26.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.8M | 97.7% | $-25.4M | $-22.3M | $— | — |
| Q4 null | $3.1M | 100.0% | $-28.4M | $-25.9M | $— | — |
| FY null | $9.0M | 100.0% | $-92.8M | $-80.6M | $— | — |
| Q3 null | $2.1M | 100.0% | $-23.1M | $-20.2M | $— | — |
| Q2 null | $2.4M | 100.0% | $-24.8M | $-21.6M | $— | — |
| Q1 null | $1.5M | 100.0% | $-16.4M | $-12.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-25.4M | $-21.1M | $— | — |
| FY null | $0.00 | NaN% | $-78.2M | $-71.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-24.8M | $-23.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-15.3M | $-13.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-12.8M | $-13.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-13.6M | $-21.0M | $-2.81 | — |